[1]
2026. CLINICAL EFFICACY AND SAFETY OF THE COMBINATION OF ROSUVASTATIN AND EZETIMIBE IN THE TREATMENT OF DYSLIPIDEMIA. Eureka Journal of Health Sciences & Medical Innovation. 2, 3 (Mar. 2026), 38–41.